Medtronic Suits Up For Patent Litigation, Bolsters Legal Team
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's recent boost in intellectual property protection resources could increase the likelihood of infringement prosecutions against competitors in the near future
You may also be interested in...
Medtronic Annual Analyst Meeting In Brief
"Paranoid" but not "paralyzed": The recent spate of Guidant recalls is not causing a "material dampening effect on the marketplace," Cardiac Rhythm Management President Steve Mahle said Oct. 11 at the firm's annual analyst meeting in Minneapolis, though he admitted that "anytime your business becomes a front page article repeatedly in the newspapers is usually not good." Mahle, who stressed Medtronic's work with AdvaMed to help determine when firms should notify patients and physicians of potential problems with their medical devices, said that the "biggest issue we have to deal with...is putting things into perspective." He added: "Survivors have to be paranoid. We're sufficiently paranoid, but we're not paranoid where we're paralyzed in terms of doing what's right for the business"...
Medtronic Annual Analyst Meeting In Brief
"Paranoid" but not "paralyzed": The recent spate of Guidant recalls is not causing a "material dampening effect on the marketplace," Cardiac Rhythm Management President Steve Mahle said Oct. 11 at the firm's annual analyst meeting in Minneapolis, though he admitted that "anytime your business becomes a front page article repeatedly in the newspapers is usually not good." Mahle, who stressed Medtronic's work with AdvaMed to help determine when firms should notify patients and physicians of potential problems with their medical devices, said that the "biggest issue we have to deal with...is putting things into perspective." He added: "Survivors have to be paranoid. We're sufficiently paranoid, but we're not paranoid where we're paralyzed in terms of doing what's right for the business"...
J&J V. Medtronic: Palmaz-Schatz Infringement Claims Sway Appeals Panel
Medtronic's invocation of the doctrine of equivalents as a legal defense against Johnson & Johnson/Cordis failed to convince a three-judge appeals court panel that Medtronic had not infringed key Cordis patents
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: